News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
PCI Hosts IvyTech Conference
Last week, PCI hosted IvyTech, an annual conference that brings together technology transfer professionals to discuss the future of research, commercialization, and intellectual property.
Penn spinout Interius Biotherapeutics raises another $21.5M
Co-founded by Saar Gill, MD, PhD, Interius is developing a new platform for cell-specific gene delivery in patients.
Penn Faculty Discover An Innovative Potential Treatment for Tooth Decay
In search of a more effective treatment, the research team employed a combination of ferumoxytol (Fer) and stannous fluoride (SnF2) to fight tooth decay.
FloBio Receives the FDA’s Breakthrough Device Designation for its Bleeding Risk Diagnostic Test
FloBio's test determines blood clotting status and identifies whether a patient is on popular blood thinners called Direct Oral Anticoagulants (DOACs).
PCI Recognized In Clinical Leader Article about How Academic Medical Centers Can Capture Greater Value In The Cell & Gene Therapy Industry
The Penn Center of Innovation was recognized in an article in Clinical Leader about how academic medical centers can leverage their unique advantages to develop and deliver cell and gene therapies.
National Academy of Medicine Elects Five Penn Experts
Five Penn experts have been elected to the National Academy of Medicine (NAM), one of the nation’s highest honors in the fields of health and medicine.
Opus Genetics Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy OPGx-LCA5 in Patients with Rare Inherited Retinal Disease LCA5
Penn spinout Opus Genetics announced that the first patient has been dosed in its Phase 1/2, first-in-human clinical trial of OPGx-LCA5.
Penn biomedical scientists move into new uCity complex with 115,000 square feet of lab space
A group of Penn scientists and engineers is moving into 115,000 square feet of new lab space in the 13-story One uCity Square building in West Philadelphia.
Team members of I Corps Team and Penn President’s Prize Winner Sonura are Named Philadelphia Business Journal’s “Inno Under 25”
The group was named as 2023’s Inno Under 25 honorees by the Philadelphia Business Journal.
PCI and Penn Medicine Represent at PHILLY BUILDS BIO+: 2ND ANNUAL SYMPOSIUM FOR LIFE SCIENCE INNOVATION AND DEVELOPMENT
Jon Epstein was keynote speaker and Ben Dibling served on a panel discussing science and technology in the context of accelerating innovation.